Target intelligence / Profile preview

Sepiapterin reductase pseudogene (SPR pseudogene (not standardized; no widely accepted abbreviation))

Target
SPR pseudogene (not standardized; no widely accepted abbreviation)
Molecular classification
Pseudogene, Non-functional gene fragment
01

Overview

This entry represents a non-coding **pseudogene** related to the functional *sepiapterin reductase* gene (SPR). Pseudogenes arise from duplication or retrotransposition of protein-coding genes but typically lack functional protein expression due to mutations, truncations, or missing regulatory sequences[1]. The ENSG00000223920 locus shares sequence similarity with SPR but does not encode an active enzyme or participate in biological pathways. The canonical SPR enzyme (not this pseudogene) is a critical oxidoreductase in tetrahydrobiopterin biosynthesis and has implications in brain function, cardiovascular disease, and pain, but pseudogenes like ENSG00000223920 have no therapeutic or biological relevance[2][4][5].

Other names
Sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) pseudogene

Beyond the preview

Go deeper on Sepiapterin reductase pseudogene (SPR pseudogene (not standardized; no widely accepted abbreviation)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sepiapterin reductase pseudogene (SPR pseudogene (not standardized; no widely accepted abbreviation)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call